IQVIA Launches AI Models to Predict Clinical Trial Outcomes
IQVIA has introduced a powerful new suite of purpose-built artificial intelligence models designed to help life sciences companies predict clinical trial outcomes with greater...
Optimizing Small Molecule Synthesis Paths Using AI
The discovery and development of small molecule drugs remain a cornerstone of the pharmaceutical industry, providing effective treatments for a wide range of diseases....
AI Analysis of Medical Imaging Making Trials More Precise
Clinical trials are the engine of pharmaceutical innovation, but they are also increasingly complex and expensive. One of the most significant bottlenecks in modern...
FDA Approves Emcitate As First Treatment for MCT8 Deficiency
The U.S. Food and Drug Administration today approved Emcitate (tiratricol) tablets for oral suspension for the treatment of peripheral thyrotoxicosis in patients with MCT8...
Optical Genome Mapping Boosting Rare Disease Diagnostics
The landscape of clinical genomics is currently witnessing a transformative shift as new technologies emerge to bridge the critical gap between traditional cytogenetics and...
Blockchain and AI Enabling Truly Personalized Drug Testing
The pharmaceutical industry is at the threshold of a new era in therapeutic development, driven by the convergence of distributed ledger technology and advanced...
Epigenetics Powering Reversible Precision Therapeutics
The pharmaceutical industry is entering a new frontier in genomic medicine, moving beyond permanent gene editing toward a more dynamic and reversible approach to...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...